When we started Dopamine, we built it around fundraising advisory. That felt like the right gap to close. Founders in the GCC were running processes without proper support, burning through relationships, and closing rounds later than they should, or not closing them at all. We thought if we brought real transaction discipline to the fundraising process, we could make a meaningful difference.
A year in, we still believe that but we have also learned something we did not fully anticipate: fundraising is increasingly not the right answer for a significant portion of the founders we meet. The gap we thought we were closing turned out to be one of several, and the more interesting ones sit on the transaction side.
Here is what twelve months of mandates have taught us.
The structure of early-stage capital in the GCC has changed in a way that most founders are not accounting for.
Pre-seed is now effectively a personal network exercise. Friends, family, and angels who know you well enough to back the idea before there is much to show. Angels have moved up the risk curve to the point where they behave more like seed investors, backing companies with early traction rather than early potential. Seed investors want proof of product-market fit before they move. Series A has become a growth vehicle. Institutional capital is no longer funding experiments.
What this means in practice is that founders often arrive at the fundraising conversation at the wrong moment with the wrong expectations. They have built something real and have early signals, but they are asking for capital to validate a thesis that investors now expect to be validated already. The round stalls. They assume it is their pitch. Often it is their timing.
A B2B SaaS company came to us with genuine commercial traction and a defensible product. The round should have moved in three months. It took significantly longer.
Part of what slowed it was structural. Early-stage rounds with angels and business advisors as participants carry complexity that founders routinely underestimate. Competing timelines, informal arrangements that had not been documented before outreach started, terms that needed cleaning up before any serious investor would commit. Keeping a round clean is unglamorous work. It is also what determines whether a process closes on the timeline you are planning around.
The broader issue runs deeper. Even with traction, GCC seed investors are moving carefully. The deals closing quickly sit in a narrow band: fintech, SME lending, SaaS with visible recurring revenue. Everything adjacent to that is taking longer than founders expect, and the valuation gap between what founders want and what investors will underwrite is real and persistent. Our consistent position: price the round to close fast. The equity you hold onto by waiting is almost always worth less than the runway you burn while the process drags.
We advised a seed-stage company with strong technical founders building in AI. The challenge was not the product or the team. It was the competitive landscape that GCC investors are watching carefully.
B2B AI verticals now attract a specific objection: global competition. A well-capitalised international player entering the region is not a risk investors can set aside. If Salesforce decided tomorrow to launch an Arabic-first CRM with a dedicated GCC go-to-market team, the question would not be whether the regional player has a better product. It would be whether any investor wants to be in the way of that. It shapes how they underwrite defensibility, think about exit timelines, and assess whether a regional AI business can hold its position long enough to generate a return. A strong technical team is necessary. In this category, right now, it is not sufficient on its own.
One portfolio company is a direct-to-consumer brand built for the global market. Consumer businesses face a consistent investor objection in the GCC: the region is a good market to test consumer products, not to scale them. The numbers alone do not return a fund.
What made them different was not the pitch. Before raising, the founder had already built the global logistics infrastructure and was selling across the US, Europe, and Asia. He had already done international expansion. When GCC investors looked at the business, they were looking at a company that had already absorbed the hardest operational challenge in DTC — global fulfilment — and was generating revenue across multiple markets simultaneously.
That changed the conversation entirely. The upside was visible and the execution risk on the thing most consumer founders treat as a future problem had already been resolved. GCC investors backed the round because the global story was already there.
The market size objection has an answer. But it has to be demonstrated before you walk in.
The more significant change we are tracking is not in fundraising. It is in how founders and companies are thinking about what comes next.
A founder who builds to seed-stage metrics has more options than most people in this market are telling them. They can raise to grow further. They can continue bootstrapped. Or they can transact: sell the company outright, merge with a strategic partner, or structure an acqui-hire that gives their team and product a larger platform to operate from.
The B2B AI company we supported came to us as a fundraising mandate and left as an acquisition. That story is worth reading in full. But it reflects a pattern that is becoming more common. Early-stage companies with genuine technical capability are being acquired by larger players who need that capability faster than they can build it. Earn-out structures are increasingly part of how those deals get done, keeping founders close to the product while giving them distribution they could not have accessed alone.
We are also seeing the reverse. Companies of various sizes are using acquisitions to diversify revenue, add adjacent product lines, and grow top-line faster than organic development allows. This is not limited to large players with cash on hand. Profitable early-stage businesses can structure share-based deals that make acquisitions viable without depleting capital, which opens the buyer pool considerably. In the GCC specifically, where building from scratch in a relatively small market requires disproportionate effort for incremental gains, acquiring a business that already has customers, contracts, and operational infrastructure compresses the timeline significantly. For small-cap and mid-market companies in the region, the acquisition route is often faster, cheaper, and lower-risk than organic growth, and that calculation is starting to show up more consistently in how our clients plan.
This is healthy for the ecosystem. It creates liquidity, puts founder experience back into the market, and opens a path to scale that does not depend on a fundraising environment that is genuinely difficult right now.
The founders navigating this well understood early that optionality is the real objective. A company built to a point where it can raise, transact, or continue on its own terms is in a fundamentally stronger position than one that has only prepared for the round.
The question worth asking is not just whether you can raise. It is which path, at this point in your company's life, actually makes sense. Working out the answer to that question before you commit to a process is increasingly where we spend our time.
